Article
CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1
28 Aug 2015
Abstract excerpt
PURPOSE: The retinoblastoma signaling network is frequently altered in advanced bladder cancer. We investigated the potential of CDK4/6 as a therapeutic target and determined biomarkers for patient stratification. MATERIALS AND METHODS: Genetic alterations were analyzed using public databases, including TCGA (The Cancer Genome Atlas), COSMIC (Catalogue of Somatic Mutations in Cancer) and CCLE (Cancer Cell Line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
